As of November 6, 2026, Cardiol Therapeutics Inc. is a publicly traded company (Nasdaq: CRDL); its largest reported holder is MMCAP International Inc. SPC, with 17.6% on Schedule 13G/A of August 14, 2026, then Tejara Capital Ltd (5.3%). No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13G/A, August 14, 2026).
Is this your company?
About to sign with, pay or invest in Cardiol Therapeutics Inc.? See the free Snapshot first.
Free to see. No signup.
Is Cardiol Therapeutics Inc. a real, registered company?
- Cardiol Therapeutics Inc. files with the SEC under CIK 1702123 (its SEC filings).
- Its shares are listed under the ticker CRDL on Nasdaq (SEC company record).
- Incorporated in A6; business address in Oakville, A6, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Cardiol Therapeutics Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Tejara Capital Ltd (filed 2026-09-23).
Who are Cardiol Therapeutics Inc.'s owners and officers?
Cardiol Therapeutics Inc.: business address in Oakville, A6; industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-09-23).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2025-11-04)
- : Executive Officer, Director (Form D, 2025-11-04)
- : Executive Officer (Form D, 2025-11-04)
- : Executive Officer (Form D, 2025-11-04)
- : Director (Form D, 2025-11-04)
- : Director (Form D, 2025-11-04)
- : Director (Form D, 2025-11-04)
- : Director (Form D, 2025-11-04)
- : Director (Form D, 2025-11-04)
- : Director (Form D, 2025-11-04)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-09-23 | Tejara Capital LTD | 5.3% |
| Schedule 13G/A, 2026-08-14 | Mmcap International Inc. Spc | 17.6% |
| Schedule 13G/A, 2026-05-15 | Mmcap International Inc. Spc | 17.9% |
| Schedule 13G, 2026-01-30 | Mmcap International Inc. Spc | 14.9% |
| Schedule 13G, 2025-10-23 | Tejara Capital LTD | 5.2% |
Questions about who owns Cardiol Therapeutics Inc.
Who owns Cardiol Therapeutics Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Cardiol Therapeutics Inc.: Mmcap International Inc. Spc (17.6%, Schedule 13G/A, filed 2026-08-14) and Tejara Capital LTD (5.3%, Schedule 13G/A, filed 2026-09-23).
Who are the largest shareholders of Cardiol Therapeutics Inc.?
By the share each holder's latest filing reports, the largest holders of Cardiol Therapeutics Inc. on this page are Mmcap International Inc. Spc (17.6%) and Tejara Capital LTD (5.3%).
When did Mmcap International Inc. Spc buy into Cardiol Therapeutics Inc.?
The filings give report dates, not purchase dates. The earliest filing from Mmcap International Inc. Spc on this page is the Schedule 13G, filed 2026-01-30, reporting 14.9%; its latest, Schedule 13G/A filed 2026-08-14, reports 17.6%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 5 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Cardiol Therapeutics Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cardiol Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cardiol Therapeutics Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
How much has Cardiol Therapeutics Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-11-04 | $760K | $8.47M |
Keep reading
More on Cardiol Therapeutics Inc. and the records around it.
Cardiol Therapeutics Inc. elsewhere on the record
- 5%+ stake filings Sep 2026
Companies that share a holder
- MMCAP International Inc. SPC also filed stake reports on 52 other companies: BHAV Acquisition Corp II (Nov 2026), Haymaker Acquisition Corp V (Sep 2026), Thunder Bridge Capital Partners V, Ltd. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/cardiol-therapeutics